| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2257.1999.00191.X |
| P698 | PubMed publication ID | 10342071 |
| P2093 | author name string | Evans G | |
| Williamson LM | |||
| Baglin TP | |||
| Luddington R | |||
| Llewelyn C | |||
| P2860 | cites work | Circulating thrombomodulin in thrombotic thrombocytopenic purpura | Q33370760 |
| Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group | Q33390678 | ||
| Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients | Q33390681 | ||
| Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura | Q33407404 | ||
| Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen | Q33442711 | ||
| Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura | Q33481821 | ||
| Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura | Q33493303 | ||
| Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group | Q33496619 | ||
| Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura | Q33496995 | ||
| Thrombotic thrombocytopenic purpura: evolution across 15 years | Q33498150 | ||
| P433 | issue | 2 | |
| P921 | main subject | thrombocytopenia | Q585285 |
| fresh frozen plasma | Q1225698 | ||
| thrombotic thrombocytopenic purpura | Q1426491 | ||
| P304 | page(s) | 119-123 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | International Journal of Laboratory Hematology | Q15751320 |
| P1476 | title | Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura | |
| P478 | volume | 21 |
| Q30441694 | A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura |
| Q33368173 | Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light |
| Q33360121 | Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura |
| Q34038164 | Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience |
| Q56675460 | Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant |
| Q33346559 | Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias |
| Q26741073 | Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use |
| Q53162993 | Increased coagulation and fibrinolytic potential of solvent-detergent plasma: a comparative study between Omniplasma and fresh frozen plasma. |
| Q33360800 | Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. |
| Q33401173 | Plasma components: properties, differences, and uses |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q33344705 | Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes |
| Q33348253 | Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura |
| Q33992794 | Viral inactivation of fresh frozen plasma |
Search more.